Cadre (CDRE) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
23 Mar, 2026Company overview and business model
Manufactures highly engineered safety equipment for professionals, with 85% of 2025 revenue from product sales and 15% from owned distribution platforms.
Products serve over 23,000 first responders and federal agencies in 104+ countries, with 21 manufacturing facilities and 2,600+ employees.
Core product categories include duty gear, EOD, body armor, and nuclear safety.
Focus on innovation, with a legacy of patented products and continuous product launches.
Operating model emphasizes lean processes, leadership development, and continuous improvement.
Financial performance and outlook
FY2025 net sales reached $610.3M, up from $567.6M in FY2024; gross margin improved to 43.9%.
Adjusted EBITDA for FY2025 was $111.7M, with a margin of 18.3%.
FY2026 guidance projects net sales of $736M–$758M and adjusted EBITDA of $136M–$141M.
Net leverage at 12/31/25 was 1.7x, with $122.9M in cash and $307.3M in total debt.
198% total shareholder return since IPO, with 17 consecutive quarterly dividends declared.
Growth strategy and M&A activity
Completed six acquisitions since IPO, focusing on strong margins, recurring revenues, and market leadership.
Recent acquisitions include TYR Tactical (2026), Carr's Engineering (2025), Alpha Safety (2024), and ICOR Technology (2024).
M&A strategy targets new markets, enhanced category leadership, and increased customer wallet share.
Acquisition multiples ranged from 5x–11x, with disciplined criteria for asset-light, recurring revenue businesses.
Integration of acquired companies aims to leverage synergies and expand product offerings.
Latest events from Cadre
- Record EBITDA and net income growth in 2025, with double-digit 2026 outlook and higher dividend.CDRE
Q4 202511 Mar 2026 - Nuclear safety and engineered products drive growth, margin expansion, and resilience.CDRE
Investor Day 20253 Feb 2026 - Apex armor and robotics launches showcase innovation and global expansion focus.CDRE
Investor Update1 Feb 2026 - Q2 net sales up 19% to $144.3M, adjusted EBITDA margin 19.6%, 2024 guidance unchanged post-cyber event.CDRE
Q2 20241 Feb 2026 - Stable demand, innovation, and operational focus drive growth and margin expansion.CDRE
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Cybersecurity incidents hit Q3, but record backlog and acquisitions support strong outlook.CDRE
Q3 202416 Jan 2026 - Strong market positions and strategic acquisitions drive growth in public safety and nuclear sectors.CDRE
CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference14 Jan 2026 - Strong Q3 2025 results and strategic acquisitions drive growth in safety and nuclear markets.CDRE
Investor presentation14 Jan 2026 - £75M acquisition doubles global nuclear scale and expands safety, robotics, and medicine reach.CDRE
M&A Announcement10 Jan 2026